Enhancing sensitivity to PARP inhibitors

被引：0
|
作者：
Sarah Crunkhorn
机构：
来源：
Nature Reviews Drug Discovery | 2021年 / 20卷 / 6期
关键词：
D O I：
10.1038/d41573-021-00078-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：426 / 426
相关论文
共 50 条
  • [41] ATM deficiency is associated with sensitivity to PARP1-and ATR inhibitors in lung adenocarcinoma
    Schmitt, A.
    Knittel, G.
    Welcker, D.
    Yang, T. -P.
    George, J.
    Nowak, M.
    Leeser, U.
    Buettner, R.
    Perner, S.
    Peifer, M.
    Reinhardt, H. C.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 247 - 247
  • [42] Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
    Murai, Junko
    Huang, Shar-yin N.
    Das, Benu Brata
    Renaud, Amelie
    Zhang, Yiping
    Doroshow, James H.
    Ji, Jiuping
    Takeda, Shunichi
    Pommier, Yves
    CANCER RESEARCH, 2012, 72 (21) : 5588 - 5599
  • [43] Combining PARP inhibitors with CPI
    Lynce, F.
    ANNALS OF ONCOLOGY, 2018, 29
  • [44] PARP Inhibitors and DNA Damage
    Byers, Lauren
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S115 - S116
  • [45] PARP Inhibitors in Ovarian Cancer
    Mittica, Gloria
    Ghisoni, Eleonora
    Giannone, Gaia
    Genta, Sofia
    Aglietta, Massimo
    Sapino, Anna
    Valabrega, Giorgio
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2018, 13 (04) : 392 - 410
  • [46] Erratum: Profiling PARP inhibitors
    Philip Jones
    Nature Biotechnology, 2012, 30 (4) : 365 - 365
  • [47] PARP inhibitors in ovarian cancer
    David Cibula
    Judith Balmaña
    British Journal of Cancer, 2015, 113 : S1 - S2
  • [48] PARP inhibitors bounce back
    Garber, Ken
    NATURE REVIEWS DRUG DISCOVERY, 2013, 12 (10) : 725 - 728
  • [49] Adverse events of PARP inhibitors
    Romanova, M.
    Klat, J.
    CESKA GYNEKOLOGIE-CZECH GYNAECOLOGY, 2021, 86 (01): : 54 - 60
  • [50] Expanding the horizons of PARP inhibitors
    Teresa Villanueva
    Nature Reviews Drug Discovery, 2010, 9 : 919 - 919
12345